fda semaglutide warning approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Bullish for compounded #tirzepatide and

This theory of liability places clinics and medspas within the scope of state consumer-protection law whenever their marketing claims diverge from the actual regulatory status of the products they administer

* Internal Medicine Specialist & Medical Director Candidate At Hospitals, medical centres and polyclinic | Transforming Patient Care through Strategic Clinical Leadership | Quality & Patient Safety Expert The Era of CardiovascularKidneyMetabolic (CKM) Medicine Has Arrived Published online on 9 June 2026, the new AHA/ACC/ADA/ASN CKM Syndrome Guideline is the first comprehensive multisociety guideline to address obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease as one interconnected disease continuum

GLP-1RAs reduce food intake and body weight by acting primarily in the brain, but theres a debate about where in the brain these drugs work

We work with clients here in Lees Summit who have varying goals and starting points

Spironolactone: Anti-androgen sometimes prescribed off-label for female hair loss, particularly when androgenetic alopecia is unmasked

Does Ozempic need to be adjusted for kidney function